National Pension Service lifted its position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 2.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 438,781 shares of the medical research company’s stock after buying an additional 11,841 shares during the period. National Pension Service owned about 0.15% of Agilent Technologies worth $56,318,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of A. Brighton Jones LLC increased its stake in shares of Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after purchasing an additional 270 shares during the last quarter. Jones Financial Companies Lllp boosted its position in shares of Agilent Technologies by 15.9% in the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after acquiring an additional 769 shares during the period. Geneos Wealth Management Inc. boosted its holdings in Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after purchasing an additional 212 shares during the period. Acadian Asset Management LLC boosted its stake in shares of Agilent Technologies by 16.5% in the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock valued at $625,000 after buying an additional 758 shares during the period. Finally, Sivia Capital Partners LLC bought a new stake in shares of Agilent Technologies during the 2nd quarter valued at $273,000.
Analysts Set New Price Targets
A has been the topic of a number of research analyst reports. Hsbc Global Res raised Agilent Technologies to a “strong-buy” rating in a report on Tuesday, January 20th. Evercore ISI raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their price objective for the stock from $155.00 to $160.00 in a research note on Monday, January 5th. The Goldman Sachs Group started coverage on shares of Agilent Technologies in a research note on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price objective on the stock. Bank of America lifted their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a report on Tuesday, November 25th. Finally, Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $164.50.
Agilent Technologies Stock Performance
Agilent Technologies stock opened at $133.84 on Monday. The firm has a market capitalization of $37.94 billion, a PE ratio of 29.29, a price-to-earnings-growth ratio of 3.89 and a beta of 1.30. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45. The firm’s 50 day simple moving average is $142.22 and its 200 day simple moving average is $134.69. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $160.27.
Agilent Technologies (NYSE:A – Get Free Report) last issued its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The firm had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. During the same quarter last year, the company posted $1.46 EPS. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.
Agilent Technologies Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th were paid a $0.255 dividend. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend was Tuesday, January 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is presently 22.32%.
Insiders Place Their Bets
In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction dated Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total value of $464,970.00. Following the transaction, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. The trade was a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 911 shares of the stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the completion of the sale, the chief executive officer owned 32,058 shares of the company’s stock, valued at approximately $4,591,987.92. This trade represents a 2.76% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 16,401 shares of company stock worth $2,468,962.
Agilent Technologies Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Recommended Stories
- Five stocks we like better than Agilent Technologies
- Trump just signed it
- GOLD ALERT
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Trump’s Final Shocking Act Begins February 24
- What Expenses Can Be Deducted From Capital Gains Tax?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
